Market Research Logo

ImmunoGen, Inc.

ImmunoGen, Inc. - Strategy and SWOT Report,

- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on ImmunoGen, Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting ImmunoGen, Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of ImmunoGen, Inc. including a breakdown and examination of key business segments
  • Intelligence on ImmunoGen, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about ImmunoGen, Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

ImmunoGen (or 'the company') is a developer of targeted anticancer therapeutics using its antibody-drug conjugate (ADC) technology. The ADC technology is comprised of the company's portfolio of cancer-cell killing agents that can be attached to antibodies for targeted delivery to cancer cells. ImmunoGen is headquartered in Waltham, Massachusetts, and employed 307 people as of June 30, 2014.Reasons to Purchase:

  • Gain understanding of ImmunoGen, Inc. and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess ImmunoGen, Inc. as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on ImmunoGen, Inc.’s business structure, strategy and prospects

  • Company Snapshot
    ImmunoGen, Inc.: Company Overview
    ImmunoGen, Inc.: Overview and Key Facts
    ImmunoGen, Inc.: Overview
    ImmunoGen, Inc.: Key Facts
    ImmunoGen, Inc.: Key Employees
    ImmunoGen, Inc.: Key Employee Biographies
    ImmunoGen, Inc.: Major Products and Services
    ImmunoGen, Inc.: Company History
    ImmunoGen, Inc.: Management Statement
    ImmunoGen, Inc.: Locations and Subsidiaries
    ImmunoGen, Inc.: Key Competitors
    ImmunoGen, Inc.: Company Analysis
    ImmunoGen, Inc.: Business Description
    ImmunoGen, Inc.: SWOT Analysis
    ImmunoGen, Inc.: SWOT Overview
    ImmunoGen, Inc.: Strengths
    ImmunoGen, Inc.: Weaknesses
    ImmunoGen, Inc.: Opportunities
    ImmunoGen, Inc.: Threats
    ImmunoGen, Inc.: Corporate Financial Deals Activity
    ImmunoGen, Inc.: Financial Deals Overview
    ImmunoGen, Inc.: Targets and Partners
    ImmunoGen, Inc.: Top Deals 2011 - 2015YTD*
    ImmunoGen, Inc.: Advisors
    ImmunoGen, Inc.: Top Legal Advisors
    ImmunoGen, Inc.: Top Financial Advisors
    ImmunoGen, Inc.: Capital Raising
    ImmunoGen, Inc.: Partnership
    ImmunoGen, Inc.: Recent Developments
    ImmunoGen, Inc.: News and Events Summary
    ImmunoGen, Inc.: Contracts
    ImmunoGen, Inc.: Corporate Governance
    ImmunoGen, Inc.: Financial Deals
    ImmunoGen, Inc.: Financial Performance
    ImmunoGen, Inc.: Regulatory and Legal Events
    ImmunoGen, Inc.: Research & Development
    Appendix
    Contact Us
    Methodology
    Definitions
    About Market Line
    List of Tables
    Table 1: ImmunoGen, Inc.: Key Facts
    Table 2: ImmunoGen, Inc.: Key Employees
    Table 4: ImmunoGen, Inc.: Key Competitors
    Table 5: ImmunoGen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
    Table 6: ImmunoGen, Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Table 7: ImmunoGen, Inc.: Targets and Partners
    Table 8: ImmunoGen, Inc.: Top Deals 2011 - 2015YTD*
    Table 9: ImmunoGen, Inc.: Legal Advisor Ranking by Value (US$m)
    Table 10: ImmunoGen, Inc.: Financial Advisor Ranking by Value (US$m)
    Table 11: ImmunoGen, Inc.: Capital Raising Volume and Value Trend (2011 - YTD*2015)
    Table 12: ImmunoGen, Inc.: Capital Raising by Deal Type (2011 - YTD*2015)
    Table 13: ImmunoGen, Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
    Table 14: ImmunoGen, Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
    Table 15: ImmunoGen, Inc.: News and Events Summary
    Table 16: ImmunoGen, Inc.: Contracts
    Table 17: ImmunoGen, Inc.: Corporate Governance
    Table 18: ImmunoGen, Inc.: Financial Deals
    Table 19: ImmunoGen, Inc.: Financial Performance
    Table 20: ImmunoGen, Inc.: Regulatory and Legal Events
    Table 21: ImmunoGen, Inc.: Research & Development
    List of Figures
    Figure 1: ImmunoGen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
    Figure 2: ImmunoGen, Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Figure 3: ImmunoGen, Inc.: Capital Raising Volume and Value Trend (2011 - YTD*2015)
    Figure 4: ImmunoGen, Inc.: Capital Raising by Deal Type (2011 - YTD*2015)
    Figure 5: ImmunoGen, Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
    Figure 6: ImmunoGen, Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Share this report